Trial Profile

Efficacy and Safety of LEO 43204 in Field Treatment of Actinic Keratosis on Balding Scalp Including 12-month Follow-up

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 02 Jan 2019

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Ingenol disoxate (Primary)
Indications Actinic keratosis
Focus Therapeutic Use
Sponsors LEO Pharma

Most Recent Events

01 Sep 2017 Status changed from active, no longer recruiting to completed.
22 Mar 2017 Status changed from recruiting to active, no longer recruiting.
26 Jan 2016 New source identified and integrated (European Clinical Trials Database EudraCT2015-002452-27).

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com